ArticlebioRxiv : the preprint server for biology2025
Retrograde viral delivery of hyper-IL-6 activates Stat3 in corticospinal tract neurons but causes severe tremors and weight loss in adult mice.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cytokines in the IL-6 family can improve axon regeneration after nervous system injury, acting in part by stimulating Stat3 phosphorylation and pro-regenerative signaling in injured neurons. Hyper-IL-6 (hIL-6) is an engineered ligand with enhanced signaling properties, shown previously to stimulate axon growth even more effectively than native IL-6 family members. Here we tested a method of hIL-6 delivery based on injection of retrograde AAV to the cervical spinal cord of adult mice. This was envisioned as a first step toward a regenerative treatment after spinal cord injury based on widespread stimulation of descending projection neurons. We found, however, that animals treated with AAV2-retro-hIL-6 developed severe tremors and weight loss within days of injection and reached criteria for humane euthanasia within five to eleven days, depending on viral dose. Examination of the cortex showed a pronounced increase in Stat3 phosphorylation in corticospinal tract (CST) neurons in hIL-6 animals versus control, confirming effective retrograde signaling. Stat3 phosphorylation and evidence of microglial activation were detected in tissue surrounding CST cell bodies and along descending CST axons, revealing extensive cytokine signaling and microglial response associated with secreted hIL-6. These results confirm the ability of hIL-6 expression to activate Stat3 signaling in CST neurons but uncover the potential for severe negative effects that must inform any further development of hIL-6 as a pro-regenerative therapeutic.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.